Investment opportunity

We are looking for funding in order to move forward with our next clinical trial. Read more below.

Investment opportunity

Company presentation in English, Finnish and Swedish

Medicortex Ppp February 2023
1.9 MB, updated on Feb 1st 2023
Medicortex Ppp Helmikuu 2023
5 MB, updated on Feb 1st 2023
Medicortex Ppp Augusti 2022
1.6 MB, updated on Sep 7th 2022

Company Executive Summaries 

Medicortex Executive Summary February 2023
232 KB, updated on Feb 1st 2023
Medicortex Yhtioesite Helmikuu 2023
247 KB, updated on Feb 1st 2023

Subscription agreement

2023 Q1 Subscription Agreement
135 KB, updated on Jan 26th 2023
2023 Q1 Merkintasopimus
114 KB, updated on Jan 26th 2023

Shares can be subscribed by filling in, printing, and signing the document above, after which the (scanned) document can be sent via email: medicortex a medicortex.fi or mail: Medicortex Finland Oyj, Itäinen Pitkäkatu 4 B, 4th floor, FI-20520 Turku, Finland. 

Financial information

The latest approved Financial statement and auditor's report:

Medicortex Financial Statement 2021
585 KB, updated on May 3rd 2022